Cystic Fibrosis Therapies to Aminoglycosides
Cystic fibrosis therapies are designed to address the underlying genetic causes and symptoms of cystic fibrosis, a hereditary disorder affecting the lungs and digestive system. These therapies aim to improve lung function, manage respiratory infections, and enhance nutrient absorption. Treatments commonly include medications that thin mucus, antibiotics to prevent and treat lung infections, pancreatic enzyme supplements, and CFTR modulators that target the defective protein caused by the genetic mutation.
-
Sale 24%
Original price $ 1,695.00Current price $ 1,285.00Tobramycin Inhalation Solution Ampules 300mg/5 mL Inhalation Antibiotic 50/Box **Refrigeration Required** (RX)
Tobramycin Inhalation Solution is used to treat chronic lung infections caused by the bacteria Pseudomonas aeruginosa in patients with cystic fibro...
View full details
Cystic fibrosis therapies are designed to address the underlying genetic causes and symptoms of cystic fibrosis, a hereditary disorder affecting the lungs and digestive system. These therapies aim to improve lung function, manage respiratory infections, and enhance nutrient absorption. Treatments commonly include medications that thin mucus, antibiotics to prevent and treat lung infections, pancreatic enzyme supplements, and CFTR modulators that target the defective protein caused by the genetic mutation.